Connection

KETANKUMAR GHAGHADA to Nanoparticles

This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Nanoparticles.
Connection Strength

6.112
  1. Nanoparticle contrast-enhanced computed tomography of sporadic aortic aneurysm and dissection: Effect of nanoparticle size and contrast agent dose. Theranostics. 2025; 15(8):3462-3473.
    View in: PubMed
    Score: 0.728
  2. Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future Opportunities. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb; 17(1):e70004.
    View in: PubMed
    Score: 0.721
  3. Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
    View in: PubMed
    Score: 0.616
  4. A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden. Contrast Media Mol Imaging. 2021; 2021:6641384.
    View in: PubMed
    Score: 0.563
  5. Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1534-1548.
    View in: PubMed
    Score: 0.550
  6. Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors. Phys Med Biol. 2019 03 12; 64(6):065007.
    View in: PubMed
    Score: 0.482
  7. Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
    View in: PubMed
    Score: 0.410
  8. Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc. 2012; 2012:27-35.
    View in: PubMed
    Score: 0.310
  9. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One. 2012; 7(4):e34496.
    View in: PubMed
    Score: 0.298
  10. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol. 2011 Jan; 18(1):20-30.
    View in: PubMed
    Score: 0.273
  11. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
    View in: PubMed
    Score: 0.127
  12. Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors. Mol Pharm. 2019 10 07; 16(10):4352-4360.
    View in: PubMed
    Score: 0.125
  13. Delivery of drugs into brain tumors using multicomponent silica nanoparticles. Nanoscale. 2019 Jun 20; 11(24):11910-11921.
    View in: PubMed
    Score: 0.123
  14. NIR-II fluorescence imaging using indocyanine green nanoparticles. Sci Rep. 2018 09 27; 8(1):14455.
    View in: PubMed
    Score: 0.117
  15. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. J Alzheimers Dis. 2016; 52(2):731-45.
    View in: PubMed
    Score: 0.097
  16. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond). 2014 Jan; 9(1):121-34.
    View in: PubMed
    Score: 0.084
  17. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J Control Release. 2014 Jan 10; 173:51-8.
    View in: PubMed
    Score: 0.083
  18. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94.
    View in: PubMed
    Score: 0.079
  19. High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):18-22.
    View in: PubMed
    Score: 0.073
  20. High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent. Magn Reson Med. 2009 Dec; 62(6):1447-56.
    View in: PubMed
    Score: 0.063
  21. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
    View in: PubMed
    Score: 0.063
  22. Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine. 2009; 4:277-82.
    View in: PubMed
    Score: 0.059
  23. A liposomal Gd contrast agent does not cross the mouse placental barrier. Sci Rep. 2016 06 14; 6:27863.
    View in: PubMed
    Score: 0.025
  24. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle. Cancer Res. 2015 Apr 01; 75(7):1356-65.
    View in: PubMed
    Score: 0.023
  25. Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev. 2014 Sep 30; 76:79-97.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.